Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Study of Clinical Non-inferiority of Actparin® (Laboratorio Bergamo) Compared to Heparin Sodium (APP Pharmaceuticals), in Patients With Chronic Renal Failure

NCT01346215 is registered in ClinicalTrials.gov with Laboratório Químico Farmacêutico Bergamo Ltda. as lead sponsor.

NCT NCT01346215
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01346215 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Study of Clinical Non-inferiority of Actparin® (Laboratorio Bergamo) Compared to Heparin Sodium (APP Pharmaceuticals), in Patients With Chronic Renal Failure
Lead sponsor
Laboratório Químico Farmacêutico Bergamo Ltda.
Phase
Phase 3
Overall status
Unknown status
Start date
October 31, 2011
Completion date
February 29, 2012
Enrollment
132 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chronic renal failure